Dexcom predicts 2025 growth, with Stelo pushing portfolio updates

1 day ago · At the same time, Dexcom predicted its year-long sales would continue to grow through 2025, with a forecast of about 14% growth to total revenues of around $4.60 billion.

CouponFollow Extension

14%
OFF

Dexcom Predicts 2025 Growth, With Stelo Pushing Portfolio Updates

2 weeks from now

1 day ago · At the same time, Dexcom predicted its year-long sales would continue to grow through 2025, with a forecast of about 14% growth to total revenues of around $4.60 billion.

fiercebiotech.com

$1.11
OFF

DexCom, Inc. - Dexcom Reports Preliminary, Unaudited Results For …

2 weeks from now

3 days ago · DexCom, Inc. (Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2024 with total revenue of at least $1.113 billion, an …

dexcom.com

5%
OFF

JP Morgan 2025: Dexcom Shares Up 5% After 2025 Outlook …

2 weeks from now

1 day ago · Dexcom released the news ahead of a presentation at the JP Morgan Healthcare 2025 conference on the same day. The diabetes device maker reported Q4 revenues of at …

yahoo.com

$1.11
OFF

Dexcom Reports Preliminary, Unaudited Results For The

2 weeks from now

3 days ago · DexCom, Inc. (Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2024 with total revenue of at least $1.113 billion, an …

morningstar.com

14%
OFF

DexCom Sees FY25 Revenue $$4.6B, Consensus $4.6B

2 weeks from now

3 days ago · For 2025, Dexcom (DXCM) currently anticipates total revenue of $4.6B, representing expected growth of approximately 14% over 2024. This outlook ...

businessinsider.com

$1.11
OFF

Dexcom CEO Talks Stelo Sensor Launch, OTC Strategy

2 weeks from now

1 day ago · Dexcom also provided a financial update, pre-announcing fourth-quarter sales of $1.11 billion and 2024 sales of $4.03 billion. The numbers were an important update for …

medtechdive.com

2%
OFF

Dexcom Earnings: Near-Term Turbulence, But Stability Should …

2 weeks from now

Oct 25, 2024 · Dexcom posted another disappointing set of results for its third quarter, featuring anemic 2% reported revenue growth, as it seeks to commercialize its new Stelo product and …

morningstar.com

FAQs about Dexcom predicts 2025 growth, with Stelo pushing portfolio updates Coupon?

How much revenue does Dexcom (DXCM) expect in 2025?

Read More on DXCM: For 2025, Dexcom (DXCM) currently anticipates total revenue of $4.6B, representing expected growth of approximately 14% over 2024. This outlook ... ...

Is Stelo a good investment for Dexcom?

So, the potential growth for DexCom entering the Type 2 Non-insulin, which Stelo targets, is gigantic. The objective of Stelo in the short term is not to improve the P&L but to increase the reach of DexCom and "test the waters" of this relatively new market. If somebody came to my office and said, we are going to make money, I would fire him. ...

How will Dexcom grow in 2025?

"Dexcom continues to execute on our vision to drive better health outcomes throughout the world through our innovative sensing technology. Our growth opportunity is truly unique and we are pleased to be in a position to raise our 2025 financial targets as we grow our global customer base with an efficient and sustainable business model." ...

What are Dexcom's financial targets for 2025?

Based on the company’s strong performance in the first two years of the target period, Dexcom is updating its year-end 2025 financial targets to the following levels: 2025 Revenue of approximately $4.6 - $5.1 billion (previously $4.0 - $4.5 billion) 2025 Non-GAAP Gross Profit Margin of 65%, consistent with prior guidance ...

Will Dexcom's results differ materially from current expectations?

The risks and uncertainties that may cause actual results to differ materially from Dexcom’s current expectations are more fully described in Dexcom’s most recent Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, as filed with the SEC on April 27, 2023. ...

Why did Dexcom stock drop 37% last year?

Dexcom’s shares dropped nearly 37% last year largely due to a reduced annual revenue forecast. At the time, the company highlighted a disruptive restructuring of its sales team, fewer customers, and decreased revenue as factors for the lower than anticipated target. Total annual revenue for 2024 came in at $4bn for the company. ...